Riskpilot← Back to searchSign inGet full accessVITALIS ASKER AS
ASActiveOrg 922708940Drengsrudhagen 6, 1385 AskerManufacture of pharmaceutical preparations · NACE 2120Est. 20190 employees
Revenue 2024
NOK 0
EBITDA margin
—
+88% vs 2023
Equity ratio
-56.4%
Financial strength
Net profit 2024
NOK -9K
+88% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -9K | +88% |
| Net profit | NOK -9K | +88% |
| Total assets | NOK 883K | +1972% |
| Equity | NOK -498K | +63% |
| Employees | 0 | — |
Legal name
VITALIS ASKER AS
Org number
922708940
Legal form
Aksjeselskap
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
6. mai 2019
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Produksjon av legemidler og farmasøytiske produkter.
Address
Drengsrudhagen 6, 1385 Asker
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −696 | −5 | −0 | −0 | −0 |
| EBITDA | −734 | −13 | −18 | −74 | −9 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −734 | −13 | −18 | −74 | −9 |
| Net financials | 1 | −2 | −51 | 0 | 0 |
| Profit before tax | −734 | −14 | −68 | −74 | −9 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −734 | −14 | −68 | −74 | −9 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 282 | 256 | 39 | 43 | 883 |
| Equity | −1 181 | −1 195 | −1 263 | −1 337 | −498 |
| Long-term debt | 1 298 | 1 298 | 1 300 | 0 | 1 381 |
| Short-term debt | 164 | 153 | 2 | 1 380 | −0 |
| Total debt | 1 462 | 1 451 | 1 302 | 1 380 | 1 381 |
EBITDA margin
-852900.0%
This company
15.8%
Market median
-5398201% vs market
20202024
Equity ratio
-56.4%
This company
38.2%
Market median
-248% vs market
20202024
Return on equity
-852900.0%
This company
18.4%
Market median
-4635426% vs market
20202024
Net profit margin
-852900.0%
This company
8.1%
Market median
-10529730% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
2.77×
This company
0.62×
Market median
-347% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
KX Chief Executive Officer | Chief Executive Officer | 2019 – 2022 |
KX Chief Executive Officer | Chief Executive Officer | 2019 – 2022 |
KX Chief Executive Officer | Chief Executive Officer | 2019 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Norsund Gruppen As
VITALIS ASKER AS Board members of VITALIS ASKER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Katrina Xue Lønmo | Chief Executive Officer | 0 companies |
| Katrina Xue-Lønmo | Chief Executive Officer | 0 companies |
| Katrina Xue | Chief Executive Officer | 0 companies |
| Yunlin Zhan | Chairman | 0 companies |